VERU INC. Deferred Tax Liabilities, Gross
VERU INC. (VERU) had Deferred Tax Liabilities, Gross of $451.16 thousand as of 2023-09-30, per its 10-K/A filed 2024-04-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2024-04-01
- 2023-09-30: Deferred Tax Liabilities, Gross $451.16K.
- 2023-06-30: Deferred Tax Liabilities, Gross $309.48K; Deferred Tax Liabilities, Gross as first filed $1.06M.
- 2023-03-31: Deferred Tax Liabilities, Gross $9.43K.
- 2022-12-31: Deferred Tax Liabilities, Gross $902.27K.
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2023-09-30 | $451.16K 10-K/A · filed 2024-04-01 | |
| 2023-06-30 | $309.48K 10-Q/A · filed 2023-11-15 | $1.06M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $9.43K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $902.27K 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $931.70K 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $910.35K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $914.39K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $918.43K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $922.47K 10-K · filed 2022-12-05 | |
| 2021-06-30 | $937.81K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $941.85K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $945.89K 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $1.32M 10-K · filed 2021-12-02 | |
| 2020-06-30 | $4.50M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $4.54M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $4.56M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $4.57M 10-K · filed 2020-12-10 | |
| 2019-06-30 | $5.27M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $5.29M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $5.31M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $5.33M 10-K · filed 2019-12-12 | |
| 2018-06-30 | $5.34M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $5.23M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $5.25M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $8.10M 10-K · filed 2018-12-13 | |
| 2017-06-30 | $8.32M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $8.32M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $8.27M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $119.92K 10-Q · filed 2017-08-09 | |
| 2015-06-30 | $165.40K 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $168.37K 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $178.28K 10-Q · filed 2015-02-03 | |
| 2014-09-30 | $190.51K 10-Q · filed 2015-07-30 | |
| 2014-06-30 | $234.01K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $234.77K 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $232.45K 10-Q · filed 2014-02-03 | |
| 2013-09-30 | $235.18K 10-K · filed 2014-12-02 | |
| 2013-06-30 | $189.72K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $192.43K 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $192.82K 10-Q · filed 2013-01-30 | |
| 2012-09-30 | $194.24K 10-K · filed 2013-12-03 | |
| 2012-06-30 | $187.56K 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $195.59K 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $188.80K 10-Q · filed 2012-01-31 | |
| 2011-09-30 | $188.18K 10-K · filed 2012-12-04 | |
| 2011-06-30 | $152.23K 10-Q · filed 2011-08-05 | |
| 2010-09-30 | $152.23K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |